ZEDI

Serial Number 77837613
Registration 3927419
800

Registration Progress

Application Filed
Sep 29, 2009
Under Examination
Approved for Publication
Dec 21, 2010
Published for Opposition
Dec 21, 2010
Registered
Mar 8, 2011

Trademark Image

ZEDI

Basic Information

Serial Number
77837613
Registration Number
3927419
Filing Date
September 29, 2009
Registration Date
March 8, 2011
Published for Opposition
December 21, 2010
Renewal Date
March 8, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 3, 2021
Registration
Registered
Classes
001 005 042

Rights Holder

Zedira GmbH

03
Address
Rösslerstrasse 83
Darmstadt 64293
DE

Ownership History

Zedira GmbH

Original Applicant
03
64293 Darmstadt DE

Zedira GmbH

Owner at Publication
03
64293 Darmstadt DE

Zedira GmbH

Original Registrant
03
Darmstadt DE

Legal Representation

Attorney
Dwayne K. Goetzel

USPTO Deadlines

Next Deadline
1949 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2011-03-08)
Due Date
March 08, 2031
Grace Period Ends
September 08, 2031

Application History

50 events
Date Code Type Description Documents
Jun 4, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 3, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 3, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 3, 2021 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Feb 26, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Mar 8, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 5, 2018 8.PR O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED Loading...
Jun 5, 2018 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
May 31, 2018 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Apr 6, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 6, 2018 PRA8 O POST REGISTRATION ACTION MAILED - SEC. 8 Loading...
Jan 19, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 19, 2017 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED Loading...
Jan 19, 2017 NA15 E SEC. 15 ACKNOWLEDGEMENT - E-MAILED Loading...
Dec 15, 2016 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 15, 2016 ES8R I TEAS SECTION 8 RECEIVED Loading...
Dec 15, 2016 E15R I TEAS SECTION 15 RECEIVED Loading...
Mar 8, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 21, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 21, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 15, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 11, 2010 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 10, 2010 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 10, 2010 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 10, 2010 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 10, 2010 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 8, 2010 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Nov 5, 2010 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Oct 26, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 25, 2010 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 25, 2010 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 25, 2010 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 25, 2010 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 25, 2010 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 20, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 20, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 18, 2010 ALIE A ASSIGNED TO LIE Loading...
Oct 15, 2010 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 4, 2010 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 4, 2010 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 4, 2010 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 15, 2010 ALIE A ASSIGNED TO LIE Loading...
Jul 15, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 15, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2010 FAXX I FAX RECEIVED Loading...
Jun 29, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 29, 2010 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 29, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 29, 2009 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 29, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...

Detailed Classifications

Class 001
Chemical and biochemical products, namely, chemicals, chemical preparations, biochemical preparations for industrial or scientific purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
[ (( Medicines for the treatment of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's diseases, Parkinson's disease, cataracts, affection by microorganisms, infections or candidiasis; pharmaceutical and veterinary medical products, namely, preparations for healthcare for the treatment of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's diseases, Parkinson's disease, cataracts, affection by microorganisms, infections or candidiasis; preparations or pharmaceuticals, namely, for the treatment and prophylaxis of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, bacterial or yeast infection, infections, or candidiasis; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for medical purposes; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for healthcare; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for human and veterinary medical use; dietetic products, namely, dietary supplements, dietetic foods adapted for medical use; dietetic products, namely, dietary supplements, dietetic foods adapted for healthcare; dietetic products, namely, dietary supplements, dietetic foods adapted for human and veterinary medical use; dietary supplements for medical purposes; disinfectants for medical instruments, for hygienic purposes, for sanitary purposes; preparations for destroying vermin; chemical and biochemical products for medical science for use in or on the human or animal body, namely, biochemical preparations and chemical reagents; diagnostic agent for medical purposes; X-ray contrast agent for medical purposes; germicidal detergents for medical purposes )) ]
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Commissioned research in the field of medical research, medical devices and biological research; conducting research and development work in the medical, pharmaceutical, pharmacological, biochemical and/or medicine technological area on behalf of third parties; commissioned execution of clinical trials and clinical studies in the field of medical and scientific research; commissioned assessment of scientific projects in the field of quality assessment and evaluation, commissioned evaluation of clinical trials and studies in the field of quality assessment and evaluation; services of a biochemical laboratory; services of an analytical laboratory in the field of medical, biological and chemical
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of an animal in the nature of a guinea pig or hamster wearing a t-shirt with the wording "ZEDI" on one sleeve.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 042